202 related articles for article (PubMed ID: 25017603)
1. Mixed primary prostatic carcinoma with acinar, neuroendocrine and ductal components.
Romero-Rojas AE; Diaz-Perez JA; Reddy A
Arch Ital Urol Androl; 2014 Jun; 86(2):150-1. PubMed ID: 25017603
[TBL] [Abstract][Full Text] [Related]
2. PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.
Morais CL; Herawi M; Toubaji A; Albadine R; Hicks J; Netto GJ; De Marzo AM; Epstein JI; Lotan TL
Prostate; 2015 Oct; 75(14):1610-9. PubMed ID: 26178158
[TBL] [Abstract][Full Text] [Related]
3. Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer.
Gillard M; Lack J; Pontier A; Gandla D; Hatcher D; Sowalsky AG; Rodriguez-Nieves J; Vander Griend D; Paner G; VanderWeele D
Eur Urol Focus; 2019 May; 5(3):433-442. PubMed ID: 29229583
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma.
Kim A; Kwon T; You D; Jeong IG; Go H; Cho YM; Hong JH; Ahn H; Kim CS
J Korean Med Sci; 2015 Apr; 30(4):385-9. PubMed ID: 25829805
[TBL] [Abstract][Full Text] [Related]
5. Histological variants of prostatic carcinoma and their significance.
Humphrey PA
Histopathology; 2012 Jan; 60(1):59-74. PubMed ID: 22212078
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical verification of ductal differentiation in prostate cancer.
Tarján M; Lenngren A; Hellberg D; Tot T
APMIS; 2012 Jun; 120(6):510-8. PubMed ID: 22583364
[TBL] [Abstract][Full Text] [Related]
7. Variants and unusual patterns of prostate cancer: clinicopathologic and differential diagnostic considerations.
Fine SW
Adv Anat Pathol; 2012 Jul; 19(4):204-16. PubMed ID: 22692283
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic Mixed Acinar-neuroendocrine-ductal Carcinoma: A Case Report and Literature Review.
Sakaguchi R; Yamada R; Nose K; Tanaka T; Murashima Y; Tsuboi J; Nakagawa H
Intern Med; 2023 Nov; 62(22):3347-3353. PubMed ID: 37032087
[TBL] [Abstract][Full Text] [Related]
9. [A prostatic duct carcinoma difficult to distinguish from transitional cell carcinoma: a case report].
Ushida H; Koizumi S; Okada Y
Hinyokika Kiyo; 2004 Aug; 50(8):535-8. PubMed ID: 15471072
[TBL] [Abstract][Full Text] [Related]
10. Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists.
Mohanty SK; Lobo A; Williamson SR; Shah RB; Trpkov K; Varma M; Sirohi D; Aron M; Kandukari SR; Balzer BL; Luthringer DL; Ro J; Osunkoya AO; Desai S; Menon S; Nigam LK; Sardana R; Roy P; Kaushal S; Midha D; Swain M; Ambekar A; Mitra S; Rao V; Soni S; Jain K; Diwaker P; Pattnaik N; Sharma S; Chakrabarti I; Sable M; Jain E; Jain D; Samra S; Vankalakunti M; Mohanty S; Parwani AV; Sancheti S; Kumari N; Jha S; Dixit M; Malik V; Arora S; Munjal G; Gopalan A; Magi-Galluzzi C; Dhillon J
Int J Surg Pathol; 2023 Sep; 31(6):993-1005. PubMed ID: 35946087
[No Abstract] [Full Text] [Related]
11. Ductal Spread Versus High-Grade Prostatic Intraepithelial Neoplasia: A Diagnostic Pitfall.
Acosta AM; Sharif A; Groth JV; Kajdacsy-Balla A
Int J Surg Pathol; 2016 Dec; 24(8):718-719. PubMed ID: 27605089
[TBL] [Abstract][Full Text] [Related]
12. Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type.
Au S; Villamil CF; Alaghehbandan R; Wang G
Ann Diagn Pathol; 2019 Apr; 39():59-62. PubMed ID: 30772651
[TBL] [Abstract][Full Text] [Related]
13. My approach to intraductal lesions of the prostate gland.
Pickup M; Van der Kwast TH
J Clin Pathol; 2007 Aug; 60(8):856-65. PubMed ID: 17237185
[TBL] [Abstract][Full Text] [Related]
14. Rare histological patterns of prostatic ductal adenocarcinoma.
Lee TK; Miller JS; Epstein JI
Pathology; 2010 Jun; 42(4):319-24. PubMed ID: 20438402
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine-type prostatic adenocarcinoma with microsatellite instability in a patient with lynch syndrome.
Wagner DG; Gatalica Z; Lynch HT; Kohl S; Johansson SL; Lele SM
Int J Surg Pathol; 2010 Dec; 18(6):550-3. PubMed ID: 20798067
[TBL] [Abstract][Full Text] [Related]
16. Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin.
Lindh C; Samaratunga H; Delahunt B; Bergström R; Chellappa V; Yaxley J; Lindberg J; Egevad L
Prostate; 2022 Apr; 82(5):576-583. PubMed ID: 35049068
[TBL] [Abstract][Full Text] [Related]
17. [Papillary adenocarcinoma of the prostate: report of 4 cases].
Miki J; Ikemoto I; Shimomura T; Kiyota H; Oisi Y; Kondo I; Madarame J; Endo K; Takahashi H
Hinyokika Kiyo; 2003 Jan; 49(1):21-4. PubMed ID: 12629776
[TBL] [Abstract][Full Text] [Related]
18. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
19. Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study.
Knipper S; Preisser F; Mazzone E; Mistretta FA; Tian Z; Briganti A; Zorn KC; Saad F; Tilki D; Graefen M; Karakiewicz PI
Clin Genitourin Cancer; 2019 Jun; 17(3):231-237.e2. PubMed ID: 31080021
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinomas of the prostatic duct in necropsy material.
Stamatiou K; Alevizos A; Mariolis A; Fanou D; Alevizou A; Michalodimitrakis E; Sofras F
Can J Urol; 2007 Apr; 14(2):3502-6. PubMed ID: 17466156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
